StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
RBC Capital Reiterates Outperform Rating on Incyte (INCY) Following 4Q Results
February 14, 2017 9:37 AM
RBC Capital Markets analyst Simos Simeonidis reiterates Outperform rating on Incyte Corporation (NASDAQ: INCY) suggesting Jakafi continues to grow, despite ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Next Articles
Incyte (INCY) PT Raised to $140 at Jefferies on 4Q Report, Jakafi Metrics
February 15, 2017 8:10 AM
Incyte (INCY) Misses Q4 EPS by 8c
February 14, 2017 7:11 AM
Incyte (INCY), Agenus (AGEN) Announce Amendment to Collaboration Agreement
February 14, 2017 7:07 AM
Incyte Reports 2016 Fourth-Quarter and Year-End Financial Results, Provides 2017 Financial Guidance and Updates on Key Clinical Programs
February 14, 2017 7:00 AM
Incyte and Agenus Amend Collaboration Agreement
February 14, 2017 7:00 AM
